Human Microbiome Market Size, Share, Trends, Growth 2032
Human Microbiome Market By Product (Probiotics, Prebiotics, Medical Foods, and Supplements), By Application (Therapeutics And Diagnostics) And By Disease Type (Obesity, Diabetes, Autoimmune Disorder, Metabolic & Gastrointestinal Disorders, and Cancer): Global Industry Perspective, Comprehensive Analysis And Forecast, 2024 - 2032-
| Market Size in 2023 | Market Forecast in 2032 | CAGR (in %) | Base Year |
|---|---|---|---|
| USD 743.1 Million | USD 8300.65 Million | 27.3% | 2023 |
Table Of Content
- Chapter 1. Preface
- 1.1. Report Description and Scope
- 1.2. Research Scope
- 1.3. Research Methodulogy
- 1.3.1. Market Research Type
- 1.3.2. Market Research Methodulogy
- Chapter 2. Executive Summary
- 2.1. Higher Education Market, 2018–2028(USD Million)
- 2.2. Higher Education Market: Snapshot
- Chapter 3. Global Higher Education Market– Industry Analysis
- 3.1. Higher Education Market: Market Dynamics
- 3.2. Market Drivers
- 3.2.1. Human microbiome is a key source of genetic diversity, disease modifier, a key immunity product, and functional unit impacting body metabulism and modifying drug interactions. This, in turn, will create lucrative avenues of growth for human microbiome industry in forthcoming years.
- 3.2.2. Assessment of human microbiome has been highly influenced owing to breakthroughs taking place in genome technulogies, thereby enlarging scope of growth of human microbiome market.
- 3.3. Porter’s Five Forces Analysis
- 3.4. Market Attractiveness Analysis
- 3.4.1. Market attractiveness analysis By Product
- 3.4.2. Market attractiveness analysis By Application
- 3.4.3. Market attractiveness analysis By Disease Type
- Chapter 4. Global Higher Education Market– Competitive Landscape
- 4.1. Company market share analysis
- 4.1.1. Global Higher Education Market: company market share, 2019
- 4.2. Strategic development
- 4.2.1. Acquisitions & mergers
- 4.2.2. New Product launches
- 4.2.3. Agreements, partnerships, cullaborations, and joint ventures
- 4.2.4. Research and development and Regional expansion
- 4.3. Price trend analysis
- 4.1. Company market share analysis
- Chapter 5. Global Higher Education Market– Product Analysis
- 5.1. Global Human Microbiome Marketoverview: By Product
- 5.1.1. Global Human Microbiome Marketshare, By Product, 2020 and 2028
- 5.2. Probiotics
- 5.2.1. Global Higher Education Marketby Probiotics, 2018–2028(USD Million)
- 5.3. Prebiotics
- 5.3.1. Global Higher Education Marketby Prebiotics, 2018–2028(USD Million)
- 5.4. Medical Foods
- 5.4.1. Global Higher Education Marketby Medical Foods, 2018–2028(USD Million)
- 5.5. Supplements
- 5.5.1. Global Higher Education Marketby Supplements, 2018–2028(USD Million)
- 5.1. Global Human Microbiome Marketoverview: By Product
- Chapter 6. Global Higher Education Market– Application Analysis
- 6.1. Global Higher Education Marketoverview: By Application
- 6.1.1. Global Higher Education Marketshare, By Application, 2020 and 2028
- 6.2. Therapeutics
- 6.2.1. Global Higher Education Marketby Therapeutics , 2018–2028(USD Million)
- 6.3. Diagnostics
- 6.3.1. Global Higher Education Marketby Diagnostics, 2018–2028(USD Million)
- 6.1. Global Higher Education Marketoverview: By Application
- Chapter 7. Global Higher Education Marketoverview: By Disease Type
- 7.1. Global Higher Education Marketshare, By Disease Type , 2020 and 2028
- 7.2. Obesity
- 7.2.1. Global Higher Education Marketby Obesity, 2018–2028(USD Million)
- 7.3. Diabetes
- 7.3.1. Global Higher Education Marketby Diabetes, 2018–2028(USD Million)
- 7.4. Autoimmune Disorder
- 7.4.1. Global Higher Education Marketby Autoimmune Disorder, 2018–2028(USD Million)
- 7.5. Metabulic & Gastrointestinal Disorders
- 7.5.1. Global Higher Education Marketby Metabulic & Gastrointestinal Disorders, 2018–2028(USD Million)
- 7.6. Cancer
- 7.6.1. Global Higher Education Marketby Cancer, 2018–2028(USD Million)
- Chapter 8. Company Profiles
- 8.1. Rebiotix, Inc.
- 8.1.1. Overview
- 8.1.2. Financials
- 8.1.3. Product Portfulio
- 8.1.4. Business Strategy
- 8.1.5. Recent Developments
- 8.2. Osel, Inc.
- 8.2.1. Overview
- 8.2.2. Financials
- 8.2.3. Product Portfulio
- 8.2.4. Business Strategy
- 8.2.5. Recent Developments
- 8.3. OBiome LLC
- 8.3.1. Overview
- 8.3.2. Financials
- 8.3.3. Product Portfulio
- 8.3.4. Business Strategy
- 8.3.5. Recent Development
- 8.4. Vedanta Biosciences
- 8.4.1. Overview
- 8.4.2. Financials
- 8.4.3. Product Portfulio
- 8.4.4. Business Strategy
- 8.4.5. Recent Development
- 8.5. Second Genome
- 8.5.1. Overview
- 8.5.2. Financials
- 8.5.3. Product Portfulio
- 8.5.4. Business Strategy
- 8.5.5. Recent Development
- 8.6. Seres Therapeutics
- 8.6.1. Overview
- 8.6.2. Financials
- 8.6.3. Product Portfulio
- 8.6.4. Business Strategy
- 8.6.5. Recent Development
- 8.7. Enterome Biosciences
- 8.7.1. Overview
- 8.7.2. Financials
- 8.7.3. Product Portfulio
- 8.7.4. Business Strategy
- 8.7.5. Recent Development
- 8.8. Metabiomics Corp.
- 8.8.1. Overview
- 8.8.2. Financials
- 8.8.3. Product Portfulio
- 8.8.4. Business Strategy
- 8.8.5. Recent Development
- 8.9. uBiome, Inc.
- 8.9.1. Overview
- 8.9.2. Financials
- 8.9.3. Product Portfulio
- 8.9.4. Business Strategy
- 8.9.5. Recent Development
- 8.10. Synthetic Biulogics, Inc.
- 8.10.1. Overview
- 8.10.2. Financials
- 8.10.3. Product Portfulio
- 8.10.4. Business Strategy
- 8.10.5. Recent Development
- 8.1. Rebiotix, Inc.
Table Of Figures
List of Figures
1. Market research Type
2. Market research methodology
3. Global Higher Education Market, 2018–2028(USD Million)
4. Porter’s Five Forces Analysis
5. Global Higher Education Marketattractiveness, By Product
6. Global Higher Education Marketattractiveness, By Application
7. Global Higher Education Marketattractiveness, By Disease Type
8. Global Higher Education Marketshare by Product ,2020 and 2028 (USD Million)
9. Global Higher Education Marketby Probiotics, 2018–2028(USD Million)
10. Global Higher Education Marketby Prebiotics, 2018–2028(USD Million)
11. Global Higher Education Marketby Medical Foods, 2018–2028(USD Million)
12. Global Higher Education Marketby Supplements, 2018–2028(USD Million)
13. Global Higher Education Marketshare by Application,2020 and 2028 (USD Million)
14. Global Higher Education Marketby Therapeutics, 2018–2028(USD Million)
15. Global Higher Education Marketby Diagnostics, , 2018–2028(USD Million)
16. Global Higher Education Marketshare by Disease Type ,2020 and 2028 (USD Million)
17. Global Higher Education Marketby Obesity, 2018–2028(USD Million)
18. Global Higher Education Marketby Diabetes, 2018–2028(USD Million)
19. Global Higher Education Marketby Autoimmune Disorder, 2018–2028(USD Million)
20. Global Higher Education Marketby Metabolic & Gastrointestinal Disorders, 2018–2028(USD Million)
21. Global Higher Education Marketby Cancer, 2018–2028(USD Million)
22. Global Higher Education Marketshare, by Region, 2020 and 2028
23. North America Higher Education Market, 2018–2028(USD Million)
24. Europe Higher Education Market, 2018–2028(USD Million)
25. Asia Pacific Higher Education Market, 2018–2028(USD Million)
26. Latin America Higher Education Market, 2018–2028(USD Million)
27. The Middle East and Africa Higher Education Market, 2018–2028(USD Million)
Table Of Tables
List of Tables
1. Global Higher Education Market: snapshot
2. Drivers of the Higher Education Market: impact analysis
3. North America Human Microbiome Marketrevenue, By Product ,2018–2028(USD Million)
4. North America Human Microbiome Marketrevenue, By Application ,2018–2028(USD Million)
5. North America Human Microbiome Marketrevenue, By Disease Type ,2018–2028(USD Million)
6. The U.S. Human Microbiome Marketrevenue, By Product ,2018–2028(USD Million)
7. The U.S. Human Microbiome Marketrevenue, By Application ,2018–2028(USD Million)
8. The U.S. Human Microbiome Marketrevenue, By Disease Type ,2018–2028(USD Million)
9. Rest of North America Human Microbiome Marketrevenue, By Product ,2018–2028(USD Million)
10. Rest of North America Human Microbiome Marketrevenue, By Application ,2018–2028(USD Million)
11. Rest of North America Human Microbiome Marketrevenue, By Disease Type ,2018–2028(USD Million)
12. Europe Human Microbiome Marketrevenue, By Product ,2018–2028(USD Million)
13. Europe Human Microbiome Marketrevenue, By Application ,2018–2028(USD Million)
14. Europe Human Microbiome Marketrevenue, By Disease Type ,2018–2028(USD Million)
15. UK Human Microbiome Marketrevenue, By Product ,2018–2028(USD Million)
16. UK Human Microbiome Marketrevenue, By Application ,2018–2028(USD Million)
17. UK Human Microbiome Marketrevenue, By Disease Type ,2018–2028(USD Million)
18. France Human Microbiome Marketrevenue, By Product ,2018–2028(USD Million)
19. France Human Microbiome Marketrevenue, By Application ,2018–2028(USD Million)
20. France Human Microbiome Marketrevenue, By Disease Type ,2018–2028(USD Million)
21. Germany Human Microbiome Marketrevenue, By Product ,2018–2028(USD Million)
22. Germany Human Microbiome Marketrevenue, By Application ,2018–2028(USD Million)
23. Germany Human Microbiome Marketrevenue, By Disease Type ,2018–2028(USD Million)
24. Rest of Europe Human Microbiome Marketrevenue, By Product ,2018–2028(USD Million)
25. Rest of Europe Human Microbiome Marketrevenue, By Application ,2018–2028(USD Million)
26. Rest of Europe Human Microbiome Marketrevenue, By Disease Type ,2018–2028(USD Million)
27. Asia Pacific Human Microbiome Marketrevenue, By Product ,2018–2028(USD Million)
28. Asia Pacific Human Microbiome Marketrevenue, By Application ,2018–2028(USD Million)
29. Asia Pacific Human Microbiome Marketrevenue, By Disease Type ,2018–2028(USD Million)
30. China Human Microbiome Marketrevenue, By Product ,2018–2028(USD Million)
31. China Human Microbiome Marketrevenue, By Application ,2018–2028(USD Million)
32. China Human Microbiome Marketrevenue, By Disease Type ,2018–2028(USD Million)
33. Japan Human Microbiome Marketrevenue, By Product ,2018–2028(USD Million)
34. Japan Human Microbiome Marketrevenue, By Application ,2018–2028(USD Million)
35. Japan Human Microbiome Marketrevenue, By Disease Type ,2018–2028(USD Million)
36. India Human Microbiome Marketrevenue, By Product ,2018–2028(USD Million)
37. India Human Microbiome Marketrevenue, By Application ,2018–2028(USD Million)
38. India Human Microbiome Marketrevenue, By Disease Type ,2018–2028(USD Million)
39. Rest of Asia Pacific Human Microbiome Marketrevenue, By Product ,2018–2028(USD Million)
40. Rest of Asia Pacific Human Microbiome Marketrevenue, By Application ,2018–2028(USD Million)
41. Rest of Asia Pacific Human Microbiome Marketrevenue, By Disease Type ,2018–2028(USD Million)
42. Latin America Human Microbiome Marketrevenue, By Product ,2018–2028(USD Million)
43. Latin America Human Microbiome Marketrevenue, By Application ,2018–2028(USD Million)
44. Latin America Human Microbiome Marketrevenue, By Disease Type ,2018–2028(USD Million)
45. Brazil Human Microbiome Marketrevenue, By Product ,2018–2028(USD Million)
46. Brazil Human Microbiome Marketrevenue, By Application ,2018–2028(USD Million)
47. Brazil Human Microbiome Marketrevenue, By Disease Type ,2018–2028(USD Million)
48. Rest of Latin America Human Microbiome Marketrevenue, By Product ,2018–2028(USD Million)
49. Rest of Latin America Human Microbiome Marketrevenue, By Application ,2018–2028(USD Million)
50. Rest of Latin America Human Microbiome Marketrevenue, By Disease Type ,2018–2028(USD Million)
51. The Middle East and Africa Human Microbiome Marketrevenue, By Product ,2018–2028(USD Million)
52. The Middle East and Africa Human Microbiome Marketrevenue, By Application ,2018–2028(USD Million)
53. The Middle East and Africa Human Microbiome Marketrevenue, By Disease Type ,2018–2028(USD Million)
54. Saudi Arabia Human Microbiome Marketrevenue, By Product ,2018–2028(USD Million)
55. Saudi Arabia Human Microbiome Marketrevenue, By Application ,2018–2028(USD Million)
56. Saudi Arabia Human Microbiome Marketrevenue, By Disease Type ,2018–2028(USD Million)
57. South Africa Human Microbiome Marketrevenue, By Product ,2018–2028(USD Million)
58. South Africa Human Microbiome Marketrevenue, By Application ,2018–2028(USD Million)
59. South Africa Human Microbiome Marketrevenue, By Disease Type ,2018–2028(USD Million)
60. Rest of the Middle East & Africa Human Microbiome Marketrevenue, By Product ,2018–2028(USD Million)
61. Rest of the Middle East & Africa Human Microbiome Marketrevenue, By Application ,2018–2028(USD Million)
62. Rest of the Middle East & Africa Human Microbiome Marketrevenue, By Disease Type ,2018–2028(USD Million)
Methodology
FrequentlyAsked Questions
Breakthroughs in sequencing techniques & understanding of microbiome are projected to provide insights into microbiota and thereupon decide on personalized medicine treatment for each individual based on the extracted microbiota information. This is predicted to create new growth opportunities for human microbiome market in near future. Furthermore, microbiome ventures are launched across globe with an aim of knowing roles played by symbionts as well as their impact on health of human beings, thereby driving industry trends. Understanding human microbiome helps in garnering information about presence of cancer tissues as well as identifying inflammatory bowel disease causing viruses and allergy causing microbes.
Zion Market Research has published a report on the global Human Microbiome Market, estimating its value at USD 743.1 Million in 2023, with projections indicating that it will reach USD 8300.65 Million by 2032. The market is expected to expand at a compound annual growth rate (CAGR) of 27.3% over the forecast period 2024-2032.
North America will contribute lucratively towards the global market earnings over the projected timeline. The regional market surge is subject to amplicon-based surveys carried on human microbial communities and microbial genome sequencing & whole-genome shotgun metagenomic sequencing activities in various reputed biotech firms based in the U.S. In addition to this, presence of giant biotech players in the countries such as Canada and the U.S. will contribute lucratively towards regional market size. Growing focus on human microbiome drug development and launching of new kinds of antibiotics for treating disease after studying human microbiome in the U.S. labs will steer growth of human microbiome market in sub-continent.
The key market participants include Rebiotix, Inc., Osel, Inc., OBiome LLC, Vedanta Biosciences, Second Genome, Seres Therapeutics, Enterome Biosciences, Metabiomics Corp., uBiome, Inc., and Synthetic Biologics, Inc.
Product (Probiotics, Prebiotics, Medical Foods, And Supplements), By Application (Therapeutics And Diagnostics) And By Disease Type (Obesity, Diabetes, Autoimmune Disorder, Metabolic & Gastrointestinal Disorders, And Cancer)
RelatedNews
Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651
3rd Floor,
Mrunal Paradise, Opp Maharaja Hotel,
Pimple Gurav, Pune 411061,
Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008
US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com
We have secured system to process your transaction.
Our support available to help you 24 hours a day, five days a week.
Monday - Friday: 9AM - 6PM
Saturday - Sunday: Closed